About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial
January 29, 2016
Click here to read more
Post navigation
Previous Post
Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial
Next Post
Phosphagenics Newsletter – February 2016
Related Posts
Receipt of R&D Tax Incentive
March 1, 2017
Phosphagenics Announces Transition of Chairman of Board
April 21, 2017
Appendix 3X Notices – Three New Directors
April 22, 2015